These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 20028513)

  • 1. Overdiagnosis in organised mammography screening in Denmark. A comparative study.
    Jørgensen KJ; Zahl PH; Gøtzsche PC
    BMC Womens Health; 2009 Dec; 9():36. PubMed ID: 20028513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The overdiagnosis nightmare: a time for caution.
    Ciatto S
    BMC Womens Health; 2009 Dec; 9():34. PubMed ID: 20015373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overdiagnosis in screening mammography in Denmark: population based cohort study.
    Njor SH; Olsen AH; Blichert-Toft M; Schwartz W; Vejborg I; Lynge E
    BMJ; 2013 Feb; 346():f1064. PubMed ID: 23444414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project.
    Ng EH; Ng FC; Tan PH; Low SC; Chiang G; Tan KP; Seow A; Emmanuel S; Tan CH; Ho GH; Ng LT; Wilde CC
    Cancer; 1998 Apr; 82(8):1521-8. PubMed ID: 9554530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program.
    Coldman A; Phillips N
    CMAJ; 2013 Jul; 185(10):E492-8. PubMed ID: 23754101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends.
    Jørgensen KJ; Gøtzsche PC
    BMJ; 2009 Jul; 339():b2587. PubMed ID: 19589821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefit-to-harm ratio of the Danish breast cancer screening programme.
    Beau AB; Lynge E; Njor SH; Vejborg I; Lophaven SN
    Int J Cancer; 2017 Aug; 141(3):512-518. PubMed ID: 28470685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overdiagnosis in the population-based service screening programme with mammography for women aged 40 to 49 years in Sweden.
    Hellquist BN; Duffy SW; Nyström L; Jonsson H
    J Med Screen; 2012 Mar; 19(1):14-9. PubMed ID: 22355181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis.
    Jørgensen KJ; Gøtzsche PC; Kalager M; Zahl PH
    Ann Intern Med; 2017 Mar; 166(5):313-323. PubMed ID: 28114661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening.
    Yen MF; Tabár L; Vitak B; Smith RA; Chen HH; Duffy SW
    Eur J Cancer; 2003 Aug; 39(12):1746-54. PubMed ID: 12888370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interpreting overdiagnosis estimates in population-based mammography screening.
    de Gelder R; Heijnsdijk EA; van Ravesteyn NT; Fracheboud J; Draisma G; de Koning HJ
    Epidemiol Rev; 2011; 33(1):111-21. PubMed ID: 21709144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimates of overdiagnosis of invasive breast cancer associated with screening mammography.
    Morrell S; Barratt A; Irwig L; Howard K; Biesheuvel C; Armstrong B
    Cancer Causes Control; 2010 Feb; 21(2):275-82. PubMed ID: 19894130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overdiagnosis and overtreatment associated with breast cancer mammography screening: A simulation study with calibration to population-based data.
    Seigneurin A; Labarère J; François O; Exbrayat C; Dupouy M; Filippi M; Colonna M
    Breast; 2016 Aug; 28():60-6. PubMed ID: 27240167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An estimate of overdiagnosis 15 years after the start of mammographic screening in Florence.
    Puliti D; Zappa M; Miccinesi G; Falini P; Crocetti E; Paci E
    Eur J Cancer; 2009 Dec; 45(18):3166-71. PubMed ID: 19879130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer incidence after the introduction of mammography screening: what should be expected?
    Svendsen AL; Olsen AH; von Euler-Chelpin M; Lynge E
    Cancer; 2006 May; 106(9):1883-90. PubMed ID: 16572411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in incidence of in situ and invasive breast cancer by histology type following mammography screening.
    Luke C; Priest K; Roder D
    Asian Pac J Cancer Prev; 2006; 7(1):69-74. PubMed ID: 16629519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ breast cancer: incidence trend and organised screening programmes in Italy.
    Barchielli A; Federico M; De Lisi V; Bucchi L; Ferretti S; Paci E; Ponti A; Buiatti E
    Eur J Cancer; 2005 May; 41(7):1045-50. PubMed ID: 15862754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overdiagnosis in screening: is the increase in breast cancer incidence rates a cause for concern?
    Paci E; Warwick J; Falini P; Duffy SW
    J Med Screen; 2004; 11(1):23-7. PubMed ID: 15006110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of screening mammography among women with and without a first-degree relative with breast cancer.
    Kerlikowske K; Carney PA; Geller B; Mandelson MT; Taplin SH; Malvin K; Ernster V; Urban N; Cutter G; Rosenberg R; Ballard-Barbash R
    Ann Intern Med; 2000 Dec; 133(11):855-63. PubMed ID: 11103055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.